BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22057004)

  • 1. Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets.
    Butt AM; Tahir S; Nasrullah I; Idrees M; Lu J; Tong Y
    Infect Genet Evol; 2012 Jan; 12(1):53-62. PubMed ID: 22057004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomics study for the identification of drug and vaccine targets in Staphylococcus aureus: MurA ligase enzyme as a proposed candidate.
    Ghosh S; Prava J; Samal HB; Suar M; Mahapatra RK
    J Microbiol Methods; 2014 Jun; 101():1-8. PubMed ID: 24685600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putative drug and vaccine target protein identification using comparative genomic analysis of KEGG annotated metabolic pathways of Mycoplasma hyopneumoniae.
    Damte D; Suh JW; Lee SJ; Yohannes SB; Hossain MA; Park SC
    Genomics; 2013 Jul; 102(1):47-56. PubMed ID: 23628646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomics study for identification of drug and vaccine targets in Vibrio cholerae: MurA ligase as a case study.
    Chawley P; Samal HB; Prava J; Suar M; Mahapatra RK
    Genomics; 2014 Jan; 103(1):83-93. PubMed ID: 24368230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target selection and deselection at the Berkeley Structural Genomics Center.
    Chandonia JM; Kim SH; Brenner SE
    Proteins; 2006 Feb; 62(2):356-70. PubMed ID: 16276528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K; Khan W; Azam SS; Wadood A
    Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
    Anishetty S; Pulimi M; Pennathur G
    Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomics analysis of Mycobacterium ulcerans for the identification of putative essential genes and therapeutic candidates.
    Butt AM; Nasrullah I; Tahir S; Tong Y
    PLoS One; 2012; 7(8):e43080. PubMed ID: 22912793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomics study of Salmonella Typhimurium LT2 for the identification of putative therapeutic candidates.
    Samal HB; Prava J; Suar M; Mahapatra RK
    J Theor Biol; 2015 Mar; 369():67-79. PubMed ID: 25637765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
    Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
    Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential genome analyses of metabolic enzymes in Pseudomonas aeruginosa for drug target identification.
    Perumal D; Lim CS; Sakharkar KR; Sakharkar MK
    In Silico Biol; 2007; 7(4-5):453-65. PubMed ID: 18391237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
    Uddin R; Masood F; Azam SS; Wadood A
    Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural genomics of minimal organisms: pipeline and results.
    Kim SH; Shin DH; Kim R; Adams P; Chandonia JM
    Methods Mol Biol; 2008; 426():475-96. PubMed ID: 18542885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtractive Genomics Approach for Identification of Novel Therapeutic Drug Targets in
    Fatoba AJ; Okpeku M; Adeleke MA
    Pathogens; 2021 Jul; 10(8):. PubMed ID: 34451385
    [No Abstract]   [Full Text] [Related]  

  • 17. In silico identification of putative drug targets from different metabolic pathways of Aeromonas hydrophila.
    Sharma V; Gupta P; Dixit A
    In Silico Biol; 2008; 8(3-4):331-8. PubMed ID: 19032165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational identification of putative common genomic drug and vaccine targets in Mycoplasma genitalium.
    Nogueira WG; Jaiswal AK; Tiwari S; Ramos RTJ; Ghosh P; Barh D; Azevedo V; Soares SC
    Genomics; 2021 Jul; 113(4):2730-2743. PubMed ID: 34118385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae.
    Barh D; Kumar A
    In Silico Biol; 2009; 9(4):225-31. PubMed ID: 20109152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico analysis of Burkholderia pseudomallei genome sequence for potential drug targets.
    Chong CE; Lim BS; Nathan S; Mohamed R
    In Silico Biol; 2006; 6(4):341-6. PubMed ID: 16922696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.